Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Lupus-Associated Collapsing Glomerulopathy; a Current Data Publisher



Ansari N1 ; Salesi M2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Rheumatology, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Nephropathology Published:2024


Abstract

Collapsing glomerulopathy is a rare but severe form of glomerular injury that can be accompanying by SLE (systemic lupus erythematosus). The pathogenesis of collapsing glomerulopathy in lupus is not well understood, and the treatment options are limited. The treatment of collapsing glomerulopathy in lupus is challenging. Immunosuppressive therapy with corticosteroids and cytotoxic agents is the mainstay of treatment. However, the response to therapy is often poor, and many patients progress to end-stage renal disease despite treatment. The use of newer agents such as rituximab and belimumab may offer additional options for the treatment of collapsing glomerulopathy in lupus. Further studies are required to better detect the underlying mechanisms of collapsing glomerulopathy in lupus and to develop more effective therapies for this condition. © 2024 The Author(s).
Related Docs
1. Relationship of Cd147 Kidney Expression With Various Pathologic Lesions, Biochemical and Demographic Data in Patients With Classes Iii and Iv of Lupus Nephritis, Journal of Nephropathology (2018)
Experts (# of related papers)
Azar Baradaran (1)